New Study of 4398 Swedish Women Shows Heel Scans by DXL Calscan are Comparable to Hip DXA Scans in Predicting Hip Fractures

The results were presented yesterday at the American Society of Bone Mineral Research (ASBMR) annual meeting in Denver, Colorado by researchers from Karolinska Institute in Sweden. These findings should lead to increased availability of bone density testing due the cost-effective and mobile scanning method available.

Stockholm, Sweden, September 14, 2009 --(PR.com)-- New data show that hip fractures can be predicted comparably as well by using scans of the heel with the DXL Calscan device (Demetech, Sweden), as scans of the hip using DXA devices. Results also showed that 78% of women who experienced a hip fracture during the follow-up period had an osteoporotic scan result at baseline from DXL Calscan, which is significantly higher than the 40-50% shown in previous studies performed using DXA hip scans. The absolute risk of hip fracture was calculated based on different levels of scan results and showed a substantially increased risk at the diagnostic cut-off point for osteoporosis.

The study authors, Assoc. Prof. Torkel Brismar, MD, PhD and Lena Toft, MD, state, “Calcaneal BMD obtained using Dual X-ray and Laser predicts future hip fractures in women with clinically suspected osteoporosis”. The authors’ conclusion: “We conclude that DXL of calcaneus should be suitable for diagnosing osteoporosis and for predicting fracture risk.”

The implications of this study could increase access to bone density scans for patients who are suspected to be “at risk” for osteoporosis. Presently, access to DXA devices is often limited to hospitals and specialist radiology centers, requiring a physician referral for a bone scan. The 19 centers participating in this study were mostly primary care facilities that are located close to patients and their personal physicians.

About the study
This multi-center study included results from 19 healthcare units and outpatient clinics throughout Sweden. Women 55 years or older were prospectively recruited and fractures were identified from the national patient register, which has been shown to have better than 98% diagnostic code accuracy and 99.7% social security code accuracy. The average follow-up period of 3 years and 11 months included a total of 17,270 person years with 130 women sustaining a hip fracture.

The 5-year hip fracture risk was 1.3% at T-scores of –2.0 or greater, but the 5-year risk was 5.4% at T-scores of –2.5 or less. The age-adjusted hazard ratio for an individual with a T-score <-2.5 versus an individual with a T-score >-2.5 was 2.64 (95% CI: 1.7-4.1, p<0.0001). The full-length study will be submitted this month to an international journal for publication.

About Demetech
Demetech develops, manufactures and markets systems for the diagnosis and early detection of osteoporosis. Demetech, headquartered in Sweden, was founded in 1996. Dual X-ray and Laser, commonly called DXL, was invented by a team of Swedish doctors, researchers and engineers. Demetech’s DXL Calscan device is the first and only instrument based on this technology. Scanflex Healthcare AB, a leading provider of state-of-the-art imaging systems for orthopedic surgery and products for personal radiation protection, acquired Demetech in 2005.

Media contact: John Elliott

###
Contact
Demetech AB
John Elliott
+46-8555-79200
http://www.demetech.com
ContactContact
Multimedia
English Press release - DXL hip fracture study

English Press release - DXL hip fracture study

Prospective hip fracture study

Argentina press release - DXL hip fracture study

Argentina press release - DXL hip fracture study

Spanish version from Buenos Aires, Proimagen SA

Spain press release - DXL hip fracture study

Spain press release - DXL hip fracture study

Spanish version from Valencia, Electromedical SA

Romania DXL hip fracture study

Romania DXL hip fracture study

Romanian version from Procardia, Tirgu Mures

Categories